Inherent Reasonableness Final Rule Suspended, But Not For Long – CMS
This article was originally published in The Gray Sheet
A final rule implementing Medicare's "inherent reasonableness" authority will be published by late November, according to CMS
You may also be interested in...
The Health Care Financing Administration intends "to move forward as quickly as possible" on a final rule about proposed reductions in Medicare reimbursement of up to 15% for lancets, eyeglass frames and indwelling catheters under the agency's "inherent reasonableness" authority.
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.